TX HHS Form 1143. Cystic Fibrosis Treatment Agents Prior Authorization Request (CSHCN)
The TX HHS Form 1143, Cystic Fibrosis Treatment Agents Prior Authorization Request (CSHCN), is a crucial document for healthcare providers to obtain prior authorization for cystic fibrosis treatment agents. This form helps solve the problem of securing necessary approvals for patients with cystic fibrosis who require specific treatments. The form is typically completed by prescribing physicians and other healthcare providers who need to request approval for treatment agents such as Pulmozyme, Inhaled Tobramycin (TOBI), Cayston, or Kalydeco.